Publicaciones en las que colabora con Gonzalo Barge Caballero (51)

2024

  1. Connective tissue amyloidosis in patients referred for orthopedic surgery. CONNECT-AMY study

    Medicina Clinica, Vol. 163, Núm. 8, pp. e84-e88

  2. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 347-349

  3. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis

    Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7

  4. Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 123-132

  5. Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 634-644

  6. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

  7. Use of SGLT2i in patients with transthyretin amyloid cardiomyopathy: prevalence and safety in a Spanish prospective cohort

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 349-352

2023

  1. Evaluación de la intervención educativa enfermera y adherencia terapéutica a los inmunosupresores en pacientes trasplantados de corazón

    Enfermería en cardiología: revista científica e informativa de la Asociación Española de Enfermería en Cardiología, Núm. 88, pp. 34-43

  2. Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes

    Transplant Immunology, Vol. 76

2022

  1. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273

  2. Cancer in patients with heart failure: Incidence, risk factors and prognostic impact

    European Journal of Internal Medicine, Vol. 105, pp. 89-96

  3. Cardiac amyloidosis: Description of a series of 143 cases

    Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213

  4. Clinical profile and causes of death according to ejection fraction in patients with heart failure cared for in a specialized Cardiology unit

    Revista Clinica Espanola, Vol. 222, Núm. 3, pp. 152-160

  5. Furosemida subcutánea mediante infusor elastomérico en pacientes ambulatorios con insuficiencia cardiaca. Experiencia inicial

    Enfermería en cardiología: revista científica e informativa de la Asociación Española de Enfermería en Cardiología, Núm. 86, pp. 45-49

  6. Prognostic value of a model based on IC-BERG recommendations in ambulatory patients with heart failure

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 76-84

  7. Real world comparison of spironolactone and eplerenone in patients with heart failure

    European Journal of Internal Medicine, Vol. 97, pp. 86-94

  8. Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes

    Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428

2021

  1. Determinants of maximal oxygen uptake in patients with heart failure

    ESC Heart Failure, Vol. 8, Núm. 3, pp. 2002-2008

  2. Dilated cardiomyopathy and mild limb girdle muscular dystrophy caused by the p.Gly424Ser genetic variant in the fukutin gene

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 987-989

  3. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors

    Medicina Clinica, Vol. 156, Núm. 8, pp. 369-378